4//SEC Filing
Klausner Richard 4
Accession 0001209191-21-042798
CIK 0001806952other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:36 PM ET
Size
8.2 KB
Accession
0001209191-21-042798
Insider Transaction Report
Form 4
Klausner Richard
Director
Transactions
- Conversion
Common Stock
2021-06-21+3,765,842→ 3,765,842 total(indirect: By LLC) - Conversion
Series A Convertible Preferred Stock
2021-06-21−3,765,842→ 0 total(indirect: By LLC)→ Common Stock (3,765,842 underlying)
Holdings
- 2,967,834
Common Stock
Footnotes (2)
- [F1]The Issuer's Series A Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date.
- [F2]The Reporting Person is a manager of Lyell Investors, LLC (Lyell Investors) and may be deemed to share the power to direct the disposition and vote of the shares held by Lyell Investors. The Reporting Person disclaims beneficial ownership of all shares held by Lyell Investors except to any pecuniary interest therein
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001591178
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 5:36 PM ET
- Size
- 8.2 KB